IP Library Granted Patent US 8,263,721
Granted Patent B2
US 8,263,721 · App. 12/417,331 · Granted Sep 11, 2012

Ophthalmic and otorhinolaryngological device materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,721
App. No.
12/417,331
Granted
Sep 11, 2012
Kind
B2
Abstract

Disclosed are soft, high refractive index device materials having improved strength. The materials contain a polystyrene macromer.

Claims (45)

1. A polymeric ophthalmic or otorhinolaryngological device material comprising;

a) a monofunctional acrylate or methacrylate monomer [1];

b) a difunctional acrylate or methacrylate cross-linking monomer [2]; and

c) an acrylate or methacrylate terminated polystyrene macromer [3] or a diacrylate or dimethacrylate terminated polystyrene macromer [4];

wherein

R, R′ independently=H, CH 3 , or CH 2 CH 3 ;

B=O(CH 2 ) n , NH(CH 2 ) n , or NCH 3 (CH 2 ) n ;

X=O(CH 2 ) n , NH(CH 2 ) n , NCH 3 (CH 2 ) n , or nothing;

n=0-6;

Y=phenyl, (CH 2 ) m H; (CH 2 ) m C 6 H 5 , OH, CH 2 CH(OH)CH 2 OH, (OCH 2 CH 2 ) m OCH 3 , or (OCH 2 CH 2 ) m OCH 2 C 3 ;

m=0-12;

Z=(CH 2 ) a , (CH 2 CH 2 O) b , O, or nothing;

D=(CH 2 ) a , O(CH 2 CH 2 O) b , O, or nothing;

a=1-12;

b=1-24;

A=CH 3 —, CH 3 CH 2 —, CH 3 CH 2 CH 2 —, CH 3 CH 2 CH 2 CH 2 —, or CH 3 CH 2 CH(CH 3 )—;

the total amount of monomer of formula (1) is at least 50% (w/w);

the total amount of macromers (3) and/or (4) is 5-40% (w/w); and

styrenic repeat units shown in macromers (3) and/or (4) are sufficiently repeated such that the material exhibits a Young's Modulus less than 6.0 and an elongation of at least 150%; and

an ingredient selected from the group consisting of a polymerizable UV absorber and a polymerizable colorant.

2. The polymeric device material of claim 1 wherein the monomer of formula (1) is selected from the group consisting of those wherein

R=H, B=O(CH 2 ) 2 , Y=phenyl; and

R=CH 3 , B=O(CH 2 ) 4 , Y=phenyl.

3. The polymeric device material of claim 1 wherein the monomer of formula (2) is selected from the group consisting of those wherein

R=H, X=OCH 2 , D=(CH 2 ) 2 ;

R=CH 3 , X=OCH 2 , D=nothing; and

R=CH 3 , X=nothing, D=O(CH 2 CH 2 O) b where b is >10.

4. The polymeric device material of claim 1 wherein the monomer of formula (2) is selected from the group consisting of ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; polyethylene oxide)dimethacrylate having a number average molecular weight of 600 to 1000; and their corresponding acrylates.

5. The polymeric device material of claim 1 wherein the macromer of formula (3) is selected from the group consisting of those wherein

R=CH 3 , R′=H, X=O(CH 2 ) 2 , Z=nothing, A=CH 3 CH 2 CH(CH 3 ); and

R=CH 3 , R′=CH 3 , X=O(CH 2 ) 2 , Z=nothing, A=CH 3 CH 2 CH(CH 3 ).

6. The polymeric device material of claim 1 wherein the macromer of formula (4) is selected from the group consisting of those wherein:

R=CH 3 , R′=H, X=O(CH 2 ) 2 , Z=nothing, A=CH 3 CH 2 CH(CH 3 ); and

R=CH 3 , R′=CH 3 , X=O(CH 2 ) 2 , Z=nothing, A=CH 3 CH 2 CH(CH 3 ).

7. The device material of claim 1 wherein the device material comprises a monomer of formula (1), a monomer of formula (2), a macromer of formula (3), and a macromer of formula (4).

8. The device material of claim 1 wherein the total amount of monomer of formula (1) is 65-85% (w/w).

9. The device material of claim 1 wherein the total amount of the monomer of formula (2) is does not exceed 15% (w/w).

10. The device material of claim 9 wherein the total amount of monomer of formula (2) is less than 3% (w/w).

11. The device material of claim 1 wherein macromer of formula (3) and the macromer of formula (4) have a number average molecular weight less than 51,000.

12. The device material of claim 1 wherein the device material has a refractive index in the dry state of at least 1.47.

13. The device material of claim 1 wherein the device material has a continuous phase glass transition temperature less than 25° C.

14. An ophthalmic or otorhinolaryngological device comprising the device material of claim 1 wherein the ophthalmic or otorhinolaryngological device is selected from the group consisting of intraocular lenses; contact lenses; keratoprostheses; corneal inlays or rings; otological ventilation tubes; and nasal implants.

15. The ophthalmic or otorhinolaryngological device of claim 14 wherein the ophthalmic or otorhinolaryngological device is an intraocular lens.

16. The ophthalmic or otorhinolaryngological device of claim 15 wherein the device material has a continuous phase glass transition temperature less than 25° C.

17. The ophthalmic or otorhinolaryngological device of claim 16 wherein the device material has a refractive index in the dry state of at least 1.47.

Assignments (1)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →